Jean-Pierre Routy
Jean-Pierre Routy
McGill University Health Centre
Verified email at
TitleCited byYear
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
L Trautmann, L Janbazian, N Chomont, EA Said, S Gimmig, B Bessette, ...
Nature medicine 12 (10), 1198, 2006
Antiretroviral-drug resistance among patients recently infected with HIV
SJ Little, S Holte, JP Routy, ES Daar, M Markowitz, AC Collier, RA Koup, ...
New England Journal of Medicine 347 (6), 385-394, 2002
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
N Chomont, M El-Far, P Ancuta, L Trautmann, FA Procopio, ...
Nature medicine 15 (8), 893, 2009
High rates of forward transmission events after acute/early HIV-1 infection
BG Brenner, M Roger, JP Routy, D Moisi, M Ntemgwa, C Matte, JG Baril, ...
The Journal of infectious diseases 195 (7), 951-959, 2007
HIV-1 viremia prevents the establishment of interleukin 2–producing HIV-specific memory CD4+ T cells endowed with proliferative capacity
SA Younes, B Yassine-Diab, AR Dumont, MR Boulassel, Z Grossman, ...
Journal of Experimental Medicine 198 (12), 1909-1922, 2003
Towards an HIV cure: a global scientific strategy
SG Deeks, B Autran, B Berkhout, M Benkirane, S Cairns, N Chomont, ...
Nature reviews Immunology 12 (8), 607, 2012
Programmed death-1–induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection
EA Said, FP Dupuy, L Trautmann, Y Zhang, Y Shi, M El-Far, BJ Hill, ...
Nature medicine 16 (4), 452, 2010
Interleukin-2 therapy in patients with HIV infection
INSIGHT–ESPRIT Study Group and SILCAAT Scientific Committee
New England Journal of Medicine 361 (16), 1548-1559, 2009
HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation
ML Dion, JF Poulin, R Bordi, M Sylvestre, R Corsini, N Kettaf, A Dalloul, ...
Immunity 21 (6), 757-768, 2004
Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection
BG Brenner, JP Routy, M Petrella, D Moisi, M Oliveira, M Detorio, B Spira, ...
Journal of virology 76 (4), 1753-1761, 2002
Peripheral blood CCR4+ CCR6+ and CXCR3+ CCR6+ CD4+ T cells are highly permissive to HIV-1 infection
A Gosselin, P Monteiro, N Chomont, F Diaz-Griffero, EA Said, S Fonseca, ...
The journal of immunology 184 (3), 1604-1616, 2010
Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use
H Salomon, MA Wainberg, B Brenner, Y Quan, D Rouleau, P CotÚ, ...
Aids 14 (2), F17-F23, 2000
Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells
H Streeck, JS Jolin, Y Qi, B Yassine-Diab, RC Johnson, DS Kwon, ...
Journal of virology 83 (15), 7641-7648, 2009
Wide variation in the multiplicity of HIV-1 infection among injection drug users
KJ Bar, H Li, A Chamberland, C Tremblay, JP Routy, T Grayson, C Sun, ...
Journal of virology 84 (12), 6241-6247, 2010
Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals
S Boulet, S Sharafi, N Simic, J Bruneau, JP Routy, CM Tsoukas, ...
Aids 22 (5), 595-599, 2008
Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomizedá…
Y Levy, I Sereti, G Tambussi, JP Routy, JD Lelievre, JF Delfraissy, ...
Clinical infectious diseases 55 (2), 291-300, 2012
Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection
AL Meditz, S MaWhinney, A Allshouse, W Feser, M Markowitz, S Little, ...
Journal of Infectious Diseases 203 (4), 442-451, 2011
Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection
B Brenner, JP Routy, Y Quan, D Moisi, M Oliveira, D Turner, MA Wainberg
Aids 18 (12), 1653-1660, 2004
Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study
A Iannello, MR Boulassel, S Samarani, O Debbeche, C Tremblay, E Toma, ...
The journal of immunology 184 (1), 114-126, 2010
A combined genotype of KIR3DL1 high expressing alleles and HLA-B* 57 is associated with a reduced risk of HIV infection
S Boulet, M Kleyman, JYJ Kim, P Kamya, S Sharafi, N Simic, J Bruneau, ...
Aids 22 (12), 1487-1491, 2008
The system can't perform the operation now. Try again later.
Articles 1–20